the ability to implement this new regimen is, in fact, a cost driver for the system, and cannot be regarded as a cost saver.
Editor's note · Context
Burgess discusses the financial implications of new healthcare policies.
Share
More from Michael Burgess
I reserve the balance of my time. Mr. McGOVERN. Madam Speaker, I yield myself the balance of my time. Madam Speaker, there is no way to sugarcoat this. We have 2 long years ahead of us. For Republicans, that likely means facing the…
For the purpose of debate only, I yield the customary 30 minutes to the gentleman from Massachusetts (Mr. McGovern), pending which I yield myself such time as I may consume. During consideration of this resolution, all time yielded is for…
I thank Dr. Bucshon from Indiana for yielding me the time on such an important reauthorization that we are undertaking today. Mr. Speaker, 2018 was the last authorization for sickle cell research. Prior to that, it had been part of the…
I thank the gentleman from Georgia for yielding. I rise today to speak in support of the rule and the underlying bills: H.R. 8771, the Department of State, Foreign Operations, and Related Programs Appropriations Act; H.R. 8752, the…





